drugset / Trial / NCT07533539
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, open, single-dose, crossover-design, phase I study to evaluate the pharmacokinetics and safety after co-administration of L03RD1 and L03RD2 or administration of L03TD1 in healthy volunteers.
Timeline
- Start
- 2026-05-09
- Primary completion
- 2026-05-24
- Completion
- 2026-06-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L03RD1 | Unknown | — | — |
| Subject | L03RD2 | Unknown | — | — |
| Subject | L03TD1 | Unknown | — | — |